Basic Information
Neurocrine Biosciences is a San Diego-based biopharmaceutical company dedicated to developing treatments for neurological and endocrine-related disorders. The company discovers, develops, and markets INGREZZA capsules, the first FDA-approved product for the treatment of adults with tardive dyskinesia (an involuntary movement disorder).
Neurocrine Biosciences, Inc.
SanDiego,California,United States of America
101~500 people
January 01, 1992
info@neurocrine.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios